OPA1 Antibodies

Santa Cruz Biotechnology offers a broad range of OPA1 monoclonal antibodies for research in mitochondrial dynamics and function. OPA1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). OPA1, a dynamin-related GTPase, plays a crucial role in the regulation of mitochondrial fusion and is essential for maintaining mitochondrial morphology and function. Dysregulation of OPA1 has been implicated in various neurodegenerative diseases and metabolic disorders, highlighting its importance in cellular health and energy metabolism. Understanding the function of OPA1 is vital for elucidating the mechanisms underlying these diseases and developing potential therapeutic strategies. OPA1 monoclonal antibodies enable researchers to investigate mitochondrial dynamics in both normal and pathological conditions. Studying OPA1's role in mitochondrial fusion provides insights into cellular energy production and maintenance. Research with OPA1 monoclonal antibodies contributes to advancing our understanding of neurodegenerative diseases and potential treatments. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in uncovering new insights into mitochondrial biology and disease mechanisms.